blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3488366

EP3488366 - METHODS AND APPARATUS FOR PREDICTING BENEFIT FROM IMMUNOTHERAPY USING TUMORAL AND PERITUMORAL RADIOMIC FEATURES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.2022
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  03.12.2021
FormerGrant of patent is intended
Status updated on  25.07.2021
FormerRequest for examination was made
Status updated on  26.04.2019
FormerThe international publication has been made
Status updated on  26.01.2018
Formerunknown
Status updated on  01.08.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Case Western Reserve University
Technology Transfer Office
10900 Euclid Avenue
Cleveland, Ohio 44106 / US
[2019/22]
Inventor(s)01 / MADABHUSHI, Anant
c/o Case Western Reserve University
Technology Transfer Office
10900 Euclid Avenue
Cleveland, Ohio 44106 / US
02 / OROOJI, Mahdi
c/o Case Western Reserve University
Technology Transfer Office
10900 Euclid Avenue
Cleveland, Ohio 44106 / US
03 / BEIG, Niha
c/o Case Western Reserve University
Technology Transfer Office
10900 Euclid Avenue
Cleveland, Ohio 44106 / US
04 / VELCHETI, Vamsidhar
c/o Case Western Reserve University
Technology Transfer Office
10900 Euclid Avenue
Cleveland, Ohio 44106 / US
 [2019/22]
Representative(s)Epping - Hermann - Fischer
Patentanwaltsgesellschaft mbH
Schloßschmidstraße 5
80639 München / DE
[2019/22]
Application number, filing date17742597.210.07.2017
[2019/22]
WO2017US41330
Priority number, dateUS201662365774P22.07.2016         Original published format: US 201662365774 P
[2019/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018017355
Date:25.01.2018
Language:EN
[2018/04]
Type: A1 Application with search report 
No.:EP3488366
Date:29.05.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 25.01.2018 takes the place of the publication of the European patent application.
[2019/22]
Type: B1 Patent specification 
No.:EP3488366
Date:05.01.2022
Language:EN
[2022/01]
Search report(s)International search report - published on:EP25.01.2018
ClassificationIPC:G16H50/20, G16H20/10, G16H30/40
[2021/31]
CPC:
G16H50/50 (EP,US); G16H50/30 (US); G06T11/003 (US);
G06T7/0012 (US); G06V20/695 (US); G06V40/1335 (US);
G16B40/10 (US); G16B50/30 (US); G16H30/20 (US);
G16H30/40 (US); G16H50/20 (EP,US); G06T2207/10081 (US);
G06T2207/30061 (US) (-)
Former IPC [2019/22]G06F19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/22]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN UND VORRICHTUNG ZUR VORHERSAGE DER VORTEILE EINER IMMUNTHERAPIE UNTER VERWENDUNG VON TUMORALEN UND PERITUMORALEN RADIOMICS EIGENSCHAFTEN[2021/32]
English:METHODS AND APPARATUS FOR PREDICTING BENEFIT FROM IMMUNOTHERAPY USING TUMORAL AND PERITUMORAL RADIOMIC FEATURES[2019/22]
French:PROCÉDÉS ET APPAREIL PERMETTANT DE PRÉDIRE UN AVANTAGE À PARTIR D'UNE IMMUNOTHÉRAPIE UTILISANT DES CARACTÉRISTIQUES RADIOMIQUES TUMORALES ET PÉRITUMORALES[2019/22]
Former [2019/22]VERFAHREN UND VORRICHTUNG ZUR VORHERSAGE DER VORTEILE EINER IMMUNTHERAPIE UNTER VERWENDUNG VON TUMORALEN UND PERITUMORALEN RADIOMIKEIGENSCHAFTEN
Entry into regional phase21.01.2019National basic fee paid 
21.01.2019Designation fee(s) paid 
21.01.2019Examination fee paid 
Examination procedure21.01.2019Examination requested  [2019/22]
21.01.2019Date on which the examining division has become responsible
11.09.2019Amendment by applicant (claims and/or description)
26.07.2021Communication of intention to grant the patent
25.11.2021Fee for grant paid
25.11.2021Fee for publishing/printing paid
25.11.2021Receipt of the translation of the claim(s)
Opposition(s)06.10.2022No opposition filed within time limit [2022/50]
Fees paidRenewal fee
29.07.2019Renewal fee patent year 03
24.07.2020Renewal fee patent year 04
22.07.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.07.2017
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
MT05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
TR05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
[2024/42]
Former [2024/29]HU10.07.2017
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
TR05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2024/22]HU10.07.2017
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2024/20]HU10.07.2017
AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2024/18]HU10.07.2017
AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2023/35]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
IT05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2023/33]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
IE10.07.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2023/21]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
LU10.07.2022
CH31.07.2022
LI31.07.2022
Former [2023/11]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/10]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SI05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/01]AL05.01.2022
AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/49]AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/48]AT05.01.2022
CZ05.01.2022
DK05.01.2022
EE05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/47]AT05.01.2022
DK05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SE05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/46]AT05.01.2022
DK05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RS05.01.2022
SE05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/42]AT05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RS05.01.2022
SE05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/39]AT05.01.2022
ES05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RS05.01.2022
SE05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
PT05.05.2022
Former [2022/36]AT05.01.2022
ES05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
NL05.01.2022
PL05.01.2022
RS05.01.2022
SE05.01.2022
BG05.04.2022
NO05.04.2022
GR06.04.2022
PT05.05.2022
Former [2022/35]ES05.01.2022
HR05.01.2022
LT05.01.2022
NL05.01.2022
RS05.01.2022
SE05.01.2022
BG05.04.2022
NO05.04.2022
PT05.05.2022
Former [2022/34]ES05.01.2022
LT05.01.2022
NL05.01.2022
NO05.04.2022
PT05.05.2022
Former [2022/33]LT05.01.2022
NL05.01.2022
NO05.04.2022
Former [2022/30]NL05.01.2022
Cited inInternational search[I]WO2015023732  (H LEE MOFFITT CANCER CT & RES [US], et al) [I] 1-19 * whole doc, in particular [0008],[0116], [0065], [0084]-[0088],[0095],[00102], [00106]-[00107] fig. 3, 7A-7B, claim 1,11 *;
 [A]US2016155225  (MADABHUSHI ANANT [US], et al) [A] 1-20* the whole document *;
 [IA]  - ADRIEN DEPEURSINGE ET AL, "Three-dimensional solid texture analysis in biomedical imaging: Review and opportunities", MEDICAL IMAGE ANALYSIS, GB, (20140101), vol. 18, no. 1, doi:10.1016/j.media.2013.10.005, ISSN 1361-8415, pages 176 - 196, XP055412366 [I] 1,16 * whole document, in particular 5.2 and 5.3 * [A] 20

DOI:   http://dx.doi.org/10.1016/j.media.2013.10.005
 [IA]  - BALAJI GANESHAN ET AL, "Quantifying tumour heterogeneity with CT", CANCER IMAGING, (20130101), vol. 13, no. 1, doi:10.1102/1470-7330.2013.0015, pages 140 - 149, XP055412359 [I] 1,16 * whole doc, in particular p.144, right col., first full paragraph. * [A] 20

DOI:   http://dx.doi.org/10.1102/1470-7330.2013.0015
 [I]  - Raghav Sundar, "Therapeutic Advances in Medical Oncology", Ther Adv Med Oncol, doi:10.1177/1758834014567470Therapeutic, (20150101), pages 85 - 96, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346216/pdf/10.1177_1758834014567470.pdf, (20160629), XP055284452 [I] 1,16 * the whole document *

DOI:   http://dx.doi.org/10.1177/1758834014567470Therapeutic
by applicant   - BRYAN A. GARNER, A Dictionary of Modern Legal Usage, (19950000), vol. 624
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.